Condensed Consolidated Balance Sheets - USD ($) $ in Thousands	Sep. 30, 2024	Dec. 31, 2023
Current assets
Cash and cash equivalents (includes restricted cash of $1,855 at December 31, 2023)	$ 114,509	$ 136,964
Accounts receivable, net of allowances of $812 and $1,118 at September 30, 2024 and December 31, 2023, respectively	16,522	18,264
Prepaid expenses	6,555	6,067
Other current assets	2,710	1,787
Total current assets	140,296	163,082
Property and equipment, net	16,385	18,880
Operating lease right-of-use assets	2,682	10,132
Intangible assets, net	3,568	8,375
Other assets	4,598	3,851
Total assets	167,529	204,320
Current liabilities
Accounts payable	7,742	6,875
Accrued employee expenses	4,993	6,667
Operating lease liabilities, current	2,285	3,240
Accrued expenses and other current liabilities	14,912	12,196
Total current liabilities	29,932	28,978
Operating lease liabilities, net of current portion	9,262	11,169
Other Liabilities, Noncurrent	347	3,958
Total liabilities	39,541	44,105
Commitments and contingencies (Note 5)
Stockholders’ Equity
Preferred stock — $0.0001 par value; 20,000,000 shares authorized at September 30, 2024 and December 31, 2023, respectively; no shares issued and outstanding at September 30, 2024 and December 31, 2023	0	0
Common stock — $0.0001 par value; 1,000,000,000 shares authorized at September 30, 2024 and December 31, 2023, respectively; 88,506,616 and 91,091,541 shares issued and outstanding at September 30, 2024 and December 31, 2023, respectively	9	9
Additional paid-in capital	715,476	722,504
Accumulated deficit	(587,497)	(562,298)
Total stockholders’ equity	127,988	160,215
Total liabilities and stockholders’ equity	$ 167,529	$ 204,320